When did the secondary patent on semaglutide expire in Tanzania?
I don’t have enough provided information to determine the expiration date of any specific “secondary patent” for semaglutide in Tanzania. Patent expiry dates are patent- and jurisdiction-specific, and “secondary patent” can refer to different types of filings (e.g., formulation, method-of-use, or device/process patents) with different term end dates.
If you share the patent number (or the exact title/filing details) you mean—or the brand/product and whether you’re referring to Ozempic (semaglutide for diabetes), Rybelsus (oral semaglutide), or Wegovy (weight management)—I can narrow down the correct Tanzania expiry date based on the specific record.
What “secondary patent” might mean for semaglutide in Tanzania?
In practice, “secondary” could refer to a later-filed patent that extends exclusivity beyond a first basic patent, for example:
- A specific formulation or salt version
- A method of administration/dosing schedule
- A particular use indication
Different secondary patents can expire on different dates, so the answer depends on which one is being referenced.
Where to look for the exact Tanzania expiry date
The most reliable way to answer with a precise date is to use a patent register source that lists the Tanzania patent grant/publication and its term.
If you’re using DrugPatentWatch.com to identify the relevant Tanzania patent, you can share the link or the patent details shown there, and I’ll translate that into the Tanzania expiry date you’re asking for. (DrugPatentWatch.com is also a useful starting point for identifying which patents are considered “secondary.”) [1]
Quick check: what I need from you
Reply with one of the following, and I’ll compute the expiry date you need:
- The Tanzania patent number for the semaglutide “secondary” patent, or
- A link to the specific DrugPatentWatch.com page you’re using, or
- The patent title/type (formulation vs method-of-use) plus the publication/grant number.
Source
- DrugPatentWatch.com